Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1847-1851, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bateman, R. M.
Right arrow Articles by Freeman, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bateman, R. M.
Right arrow Articles by Freeman, D. J.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1847-1851.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Effect of Hemolyzed Plasma on the Batch Measurement of Nitrate by Nitric Oxide Chemiluminescence

Ryon M. Bateman1,2, Christopher G. Ellis1,2, Michael D. Sharpe3, Sanjay Mehta4 and David J. Freeman5a

1 Vascular Biology Program, Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, N6B 1B8 Canada
Departments of
2 Medical Biophysics,
3 Anaesthesia,
4 Respirology, and
5 Pharmacology-Toxicology, University of Western Ontario, London, Ontario, N6A 5C1 Canada

aaddress correspondence to this author at: Department of Medicine and Pharmacology-Toxicology, University of Western Ontario, London, Ontario, N6A 5C1 Canada; fax 519-663-3789, e-mail dfreeman@uwo.ca

Nitric oxide (NO) is a potent vasodilator and regulator of vascular tone, a neurotransmitter, and a cytotoxic agent (1)(2). In aqueous aerobic environments, the primary decomposition product of NO is nitrite (NO2-) (3), with further oxidation to nitrate (NO3-) being dependent on the presence of additional oxidizing species such as oxyhemoproteins (3). Collectively, these NO oxidation products are referred to as NOx-. Several analytical techniques have been used to quantify NOx- species, including spectrophotometric assays based on the Griess reaction (4)(5) and enzymatic reduction of NO3- (6), gas chromatography–mass spectrometry (7), chromatographic flow systems (8), and chemiluminescence (9)(10)(11).

NOx- may be important in sepsis (12)(13)(14)(15)(16). Of possible analytical importance is intravascular hemolysis during sepsis (17)(18)(19). The effect of hemolysis on NOx- analysis is unknown. Other potential causes of intravascular hemolysis include drug-induced hemolytic anemia, hemolytic transfusion reactions, and artificial heart valves (20), and hemolysis can also occur during blood collection (21) and inappropriate blood storage. The objectives of our study were (a) to determine whether hemolysis interferes with the determination of plasma NO3- by NO chemiluminescence batch methodology and (b) to determine whether the interference could be eliminated by sample pretreatment.

We purchased helium and oxygen from Praxair. Other chemicals were from Sigma-Aldrich. All chemicals were reagent-grade quality. Deionized water was used to prepare all solutions. Blood samples were obtained from healthy human volunteers by venipuncture with heparin as anticoagulant. Aqueous NO3- calibrators (25 µmol/L) were prepared in deionized water. Digitonin in phosphate-buffered saline (PBS), at final concentrations of 0, 20, 45, and . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
R. M. Bateman, C. G. Ellis, and D. J. Freeman
Optimization of Nitric Oxide Chemiluminescence Operating Conditions for Measurement of Plasma Nitrite and Nitrate
Clin. Chem., March 1, 2002; 48(3): 570 - 573.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.